INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 151 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $515,000 | -19.8% | 23,245 | -0.5% | 0.00% | 0.0% |
| Q1 2024 | $642,000 | -11.3% | 23,358 | -1.8% | 0.00% | 0.0% |
| Q4 2023 | $724,000 | -10.4% | 23,797 | -7.0% | 0.00% | -50.0% |
| Q3 2023 | $808,000 | -29.1% | 25,579 | -8.4% | 0.00% | 0.0% |
| Q2 2023 | $1,139,000 | +7.9% | 27,939 | -1.5% | 0.00% | 0.0% |
| Q1 2023 | $1,056,000 | +16.0% | 28,366 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $910,000 | -41.5% | 26,087 | -6.1% | 0.00% | -50.0% |
| Q3 2022 | $1,555,000 | +8.1% | 27,795 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $1,438,000 | -40.4% | 27,683 | -16.4% | 0.00% | -20.0% |
| Q1 2022 | $2,411,000 | -45.0% | 33,112 | -10.6% | 0.01% | -50.0% |
| Q4 2021 | $4,384,000 | +1.6% | 37,057 | +15.1% | 0.01% | -16.7% |
| Q3 2021 | $4,317,000 | -6.6% | 32,184 | +12.8% | 0.01% | -7.7% |
| Q2 2021 | $4,622,000 | +65.3% | 28,524 | -18.2% | 0.01% | +44.4% |
| Q1 2021 | $2,796,000 | +74.2% | 34,856 | +17.9% | 0.01% | +28.6% |
| Q4 2020 | $1,605,000 | +112.3% | 29,552 | -22.4% | 0.01% | +75.0% |
| Q3 2020 | $756,000 | +140.8% | 38,104 | +155.7% | 0.00% | +100.0% |
| Q2 2020 | $314,000 | +86.9% | 14,900 | +8.2% | 0.00% | +100.0% |
| Q1 2020 | $168,000 | -23.3% | 13,775 | -8.7% | 0.00% | 0.0% |
| Q4 2019 | $219,000 | -5.2% | 15,083 | -12.9% | 0.00% | 0.0% |
| Q3 2019 | $231,000 | -61.4% | 17,325 | -52.5% | 0.00% | -75.0% |
| Q2 2019 | $598,000 | +0.7% | 36,437 | +5.3% | 0.00% | 0.0% |
| Q1 2019 | $594,000 | +195.5% | 34,611 | +135.0% | 0.00% | +100.0% |
| Q4 2018 | $201,000 | -44.2% | 14,726 | +16.8% | 0.00% | -33.3% |
| Q3 2018 | $360,000 | +59.3% | 12,611 | +52.6% | 0.00% | +50.0% |
| Q2 2018 | $226,000 | -22.9% | 8,266 | -45.6% | 0.00% | 0.0% |
| Q4 2017 | $293,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |